Deepika Delsa Dean1, Sarita Agarwal2, Deepa Kapoor3, Kuldeep Singh4, Chandra Vati5. 1. Department of Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226014, India. 2. Department of Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226014, India. saritasgpgi@gmail.com. 3. Department of Obstetrics and Gynecology, General Hospital, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226014, India. 4. Department of Pediatrics, AIIMS, Jodhpur, Rajasthan, India. 5. Department of Obstetrics and Gynecology, Krishna Medical Centre, Lucknow, India.
Abstract
BACKGROUND: Fragile X syndrome is caused by CGG repeat expansion mutation in the FMR1 gene. Normal alleles have 5-44 CGG repeats with AGG interruptions. The expanded gray zone (GZ) (45-54 repeats) and premutation (PM) (55-200 repeats) alleles are often uninterrupted and are unstably inherited in subsequent generations. The prevalence of PM and GZ carriers is high in the female population, at 1/66 and 1/113, respectively, and PM is associated with fertility problems in 20% of cases. OBJECTIVE: Our objective was to molecularly characterize CGG repeats and AGG interruption sequences in the FMR1 gene in women of reproductive age and in women with premature ovarian insufficiency (POI). MATERIALS AND METHODS: We conducted molecular analysis of the FMR1 gene from 300 women of reproductive age and 140 women with POI using triplet primed-polymerase chain reaction. This enabled us to identify carriers and to document CGG repeat size and the AGG interruption pattern. RESULTS: In women of reproductive age, 1.7% were GZ carriers and 0.3% were PM carriers; in women with POI, 3.6% were GZ carriers and 2.14% were PM carriers. The frequency of GZ and PM carriers did not significantly differ between the cohorts (Fisher's exact test: p < 2.23 for GZ vs. control and p < 0.101 for PM vs. control). Carriers received genetic counselling; family screening identified an additional seven carriers. CONCLUSION: We documented preliminary data on the prevalence of GZ and PM carriers among the studied cohorts. The identification of PM carriers among women with POI serves a dual purpose of recognizing a cause for ovarian dysfunction and enabling genetic counselling, which will help carriers when making reproductive decisions.
BACKGROUND:Fragile X syndrome is caused by CGG repeat expansion mutation in the FMR1 gene. Normal alleles have 5-44 CGG repeats with AGG interruptions. The expanded gray zone (GZ) (45-54 repeats) and premutation (PM) (55-200 repeats) alleles are often uninterrupted and are unstably inherited in subsequent generations. The prevalence of PM and GZ carriers is high in the female population, at 1/66 and 1/113, respectively, and PM is associated with fertility problems in 20% of cases. OBJECTIVE: Our objective was to molecularly characterize CGG repeats and AGG interruption sequences in the FMR1 gene in women of reproductive age and in women with premature ovarian insufficiency (POI). MATERIALS AND METHODS: We conducted molecular analysis of the FMR1 gene from 300 women of reproductive age and 140 women with POI using triplet primed-polymerase chain reaction. This enabled us to identify carriers and to document CGG repeat size and the AGG interruption pattern. RESULTS: In women of reproductive age, 1.7% were GZ carriers and 0.3% were PM carriers; in women with POI, 3.6% were GZ carriers and 2.14% were PM carriers. The frequency of GZ and PM carriers did not significantly differ between the cohorts (Fisher's exact test: p < 2.23 for GZ vs. control and p < 0.101 for PM vs. control). Carriers received genetic counselling; family screening identified an additional seven carriers. CONCLUSION: We documented preliminary data on the prevalence of GZ and PM carriers among the studied cohorts. The identification of PM carriers among women with POI serves a dual purpose of recognizing a cause for ovarian dysfunction and enabling genetic counselling, which will help carriers when making reproductive decisions.
Authors: Claire E Bennett; Gerard S Conway; James N Macpherson; Patricia A Jacobs; Anna Murray Journal: Hum Reprod Date: 2010-03-13 Impact factor: 6.918
Authors: A K Sullivan; M Marcus; M P Epstein; E G Allen; A E Anido; J J Paquin; M Yadav-Shah; S L Sherman Journal: Hum Reprod Date: 2004-12-17 Impact factor: 6.918
Authors: H Toledano-Alhadef; L Basel-Vanagaite; N Magal; B Davidov; S Ehrlich; V Drasinover; E Taub; G J Halpern; N Ginott; M Shohat Journal: Am J Hum Genet Date: 2001-07-06 Impact factor: 11.025
Authors: E G Allen; A K Sullivan; M Marcus; C Small; C Dominguez; M P Epstein; K Charen; W He; K C Taylor; S L Sherman Journal: Hum Reprod Date: 2007-06-22 Impact factor: 6.918
Authors: Sarah L Nolin; Anne Glicksman; Nicole Ersalesi; Carl Dobkin; W Ted Brown; Ru Cao; Eliot Blatt; Sachin Sah; Gary J Latham; Andrew G Hadd Journal: Genet Med Date: 2014-09-11 Impact factor: 8.822
Authors: Flora Tassone; Ka Pou Iong; Tzu-Han Tong; Joyce Lo; Louise W Gane; Elizabeth Berry-Kravis; Danh Nguyen; Lisa Y Mu; Jennifer Laffin; Don B Bailey; Randi J Hagerman Journal: Genome Med Date: 2012-12-21 Impact factor: 11.117
Authors: Artur Beke; Henriett Piko; Iren Haltrich; Veronika Karcagi; Janos Rigo; Maria Judit Molnar; György Fekete Journal: BMC Med Genet Date: 2018-07-09 Impact factor: 2.103